Pituitary Carcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors (NCT04042753) | Memorial Sloan Kettering Cancer Center | 2019-07-31 |
Track Pituitary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.